re: nation wide news coverage Capman,
the market ignores everything Novogen says...lol.
That's one thing you should consider with Novogen. The management don't hype the company up unlike all the other biotechs out there. They just do the science and when they get FDA approval the share price will take care of itself.
Cheers,
Munch